#+Title: Mitochondria Disease
#+options: title:nil toc:nil num:nil author:nil date:nil
#+latex_class: article
#+latex_class_options:[landscape]
#+latex_header: \usepackage{longtable}
#+latex_header: \usepackage[margin=0.45in]{geometry}
#+latex_header:
#+latex_header_extra:
#+description:
#+keywords:
#+subtitle:

#+CAPTION[]: Mitochondrial Disease
#+NAME: tab:mtdna
#+ATTR_LATEX: :environment longtable :float sideways
| Syndrome      | Phenotype                                 | Onset       | Molecular                           | Labs                                    |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| CoQ           | Encephalomyopathy, ataxia,                | Neonatal    | AR :: 10 CoQ and assembly genes     | \uparrow L/P(B,C)                       |
|               | nephrotic syndrome                        | Child       |                                     | \downarrow CoQ(T)                       |
|               |                                           |             |                                     | \downarrow CI + CIII activity(T,F)      |
|               |                                           |             |                                     | \downarrow CII + CIII activity(T,F)     |
|               |                                           |             |                                     | N CI, CII, CII activity(T,F)            |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| MDDS          | Primary manifestation can be:             | Neonatal    | AR :: POLG, twinkle, TK2, DGUOK,    | \uparrow L/P(B,C)                       |
|               | encephalohepatopathy, encephalomyopathy,  | Infancy     | SUCLA2, SUCLG1, RRM2B               | \uparrow MMA[fn:mma]                    |
|               | encephaloneuropathy,                      |             |                                     | \downarrow mtDNA(T)                     |
|               | myopathy, neuropathy,                     |             |                                     | \downarrow CI, CIII, CIV activity(T,F)  |
|               | PEO, optic atrophy                        |             |                                     | N/\uparrow CII activity(T,F)            |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| Pearson       | Exocrine pancreatic dysfunction,          | Infancy     | mtDNA :: deletion                   | \uparrow L/P(B,C)                       |
|               | sideroblastic anemia                      |             |                                     | mtDNA del/dup(T,U)                      |
|               |                                           |             |                                     | \downarrow CI, CIII, CIV activity(T,F)  |
|               |                                           |             |                                     | RRF, COX -ve, SDH +ve(T)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| MEGDEL        | 3-MEthylGlutaconic aciduria, Deafness,    | Infancy     | AR :: SERAC1                        | \uparrow L/P(B)                         |
|               | Encephalopathy and Leigh-like disease     |             |                                     | \uparrow 3-MGA, 3-MGC(U)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| Leigh         | Subacute necrotising encephalopathy,      | Infancy     | AR :: SURF1, SDHA, COX assembly, CI | \uparrow/N L/P(B,C)[fn:pdh]             |
|               | bilateral symetrical lesions on MRI,      | Child       | XL :: PDHA1 (PDHC E1\alpha subunit) | mtDNA del/dup(T,U)                      |
|               | hypotonia, ataxia, peripheral neuropathy  |             | mtDNA :: deletion, MT-ATP6          | N\downarrow CI, CIII, CIV activity(T,F) |
|               |                                           |             | ~75% nDNA                           | RRF,COX -ve, SDH +ve(T)                 |
| NARP[fn:narp] | Neuropathy, Ataxia, RP, weakness          | Child       |                                     |                                         |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| MNGIE         | Neuro-GastroIntestinal Encephalopathy     | Child       | AR :: TYMP                          | \uparrow L/P(B,C)                       |
|               | GI dysmotility, ptosis, PEO               |             |                                     | \uparrow thymidine, deoxyuridine(U,P)   |
|               |                                           |             |                                     | \downarrow mtDNA(T)                     |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| KSS           | PEO, RP, ptosis, ataxia, ID,              | Child-Teen  | mtDNA :: deletion                   | \uparrow L/P(B,C)                       |
|               | hearing loss, weakness                    |             |                                     | mtDNA del/dup(T,U)                      |
|               |                                           |             |                                     | \downarrow CI, CIII, CIV activity(T,F)  |
|               |                                           |             |                                     | RRF, COX -ve, SDH +ve(T)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| MELAS         | Encephalopathy, Lactic acidosis, Stroke,  | Child-Adult | mtDNA :: MT-TL1, MT-ND5             | \uparrow L/P(B,C)                       |
|               | blindness, hearing loss, muscle weakness, |             |                                     | \downarrow CI activity(T,F)             |
|               | seizures, psychomotor regression          |             |                                     | RRF, COX +ve, SDH +ve(T)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| LHON          | Optic Neuropathy \to blindness            | Teen-Adult  | mtDNA :: MT-ND1, MT-ND4, MT-ND6     | \uparrow L/P(B,C)                       |
|               |                                           |             |                                     | \downarrow CI activity(T,F)             |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| MERRF         | Myoclonic Epilepsy, RRF, ataxia           | Child-Adult | mtDNA :: MT-TK                      | \uparrow L/P(B,C)                       |
|               |                                           |             |                                     | N\downarrow CIV activity(T,F)           |
|               |                                           |             |                                     | RRF, COX -ve, SDH +ve(T)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|
| CPEO          | Progressive External Ophthalmoplegia,     | Adult       | mtDNA :: deletion                   | \uparrow L/P(B,C)                       |
|               | ptosis, proximal limb weakness            |             | AR :: POLG                          | mtDNA del/dup(T,U)                      |
|               |                                           |             | AD :: POLG                          | \downarrow CI, CIII, CIV activity(T,F)  |
|               |                                           |             |                                     | RRF, COX -ve, SDH +ve(T)                |
|---------------+-------------------------------------------+-------------+-------------------------------------+-----------------------------------------|

- Abbreviations :: RP, retinitis pigmentosa; U, urine; UOA, urine
  organic acids; P, plasma; B, blood; C, CSF; T, tissue; F,
  fibroblasts; 3-MGA, 3-methylglutaconic; 3-MGC, 3-methylglutaric

- Genes
  - MT-TL1 :: tRNA^{Leu(UUR)} \to MELAS
  - MT-TK :: tRNA^{Lys} \to MERRF
  - MT-ND1,4,6 :: CI \to LHON
  - MT-ND5 :: CI \to MELAS
  - MT-ATP6 :: CV \to Leigh, NARP
  - SURF1 :: regulation of cytochrome c oxidase assembly \to Leigh
  - twinkle :: mtDNA helicase \to MDDS
  - TK2 :: thymidine kinase \to MDDS
  - DGUOK :: deoxyguanosine kinase \to MDDS
  - SUCLA2/SUCLG1 :: succinyl-CoA ligase  \to MDDS
  - RRM2B :: ribonucleotide reductase \to MDDS
  - POLG :: polymerase \gamma \to MDDS, adCPEO, arCPEO
  - TYMP :: thymidine phosphorylase \to MNGIE
  - SERAC1 :: phosphatidylglycerol remodeling \to MEGDEL

[fn:narp] mtDNA-associated Leigh syndrome and NARP are part of a
continuum of progressive neurodegenerative disorders caused by
abnormalities of mitochondrial energy generation
[fn:pdh] Normal L/P ratio in PDH deficiency
[fn:mma] SUCLA2 and SUCLG1 deficiency

* COMMENT Maintainance
#+CAPTION[]:Nuclear Gene Involved in Mitochondrial Maintainance
#+NAME: tab:ndna
#+ATTR_LATEX: :environment longtable :float sideways
| Gene                                   | Phenotype                                      | Inheritance |
|----------------------------------------+------------------------------------------------+-------------|
| *DNA replication/repair*               |                                                |             |
| POLG                                   | MCHS, Alpers–Huttenlocher, ANS, adCPEO, arCPEO | AD, AR      |
| C10orf2                                | adCPEO, IOSCA, Epileptic encephalopathy        | AD, AR      |
| POLG2                                  | adCPEO, arCPEO                                 | AD          |
| DNA2                                   | adCPEO                                         | AD          |
| MGME1                                  | arCPEO, Myopathy                               | AR          |
| APTX                                   | Ataxia, Oculomotor apraxia                     |             |
|----------------------------------------+------------------------------------------------+-------------|
| *dNTP pools*                           |                                                |             |
| TYMP                                   | MNGIE                                          | AR          |
| DGUOK                                  | Hepatocerebral syndrome                        | AR          |
| TK2                                    | Myopathy, arCPEO, SMA phenocopy                | AR          |
| RRM2B*                                 | adCPEO, arCPEO, Myopathy, Tubulopathy          | AD, AR      |
| SUCLA2                                 | Encephalomyopathy (Leigh syndrome-like)        | AR          |
| SUCLG1                                 | Encephalomyopathy (Leigh syndrome-like)        | AR          |
| DUK1*                                  | Myopathy, hepatopathy                          | AR          |
| MPV17                                  | Encephalohepatopathy, Navajo neuroheptaopthy   | AR          |
|                                        | arCPEO                                         |             |
| ABAT                                   | Psychomotor retardation, seizures              | AR          |
|----------------------------------------+------------------------------------------------+-------------|
| *Mito network dynamics*                |                                                |             |
| OPA1                                   | Opticatrophy                                   | AD          |
| MFN2                                   | Peripheral neuropathy, optic neuropathy        | AR          |
|----------------------------------------+------------------------------------------------+-------------|
| *Mito transcription*                   |                                                |             |
| TRAM                                   | Hepatopathy, myopathy                          | AR          |
| *Mito protein synthesis & maintenance* |                                                |             |
| SPG7                                   | arCPEO                                         | AR          |
| AFG3L2                                 | arCPEO, ataxia                                 | AR          |
| *Mito protein import*                  |                                                |             |
| GFER                                   | Cataract, myopathy, sensorineural hearing loss | AR          |
| *Mito carrier transporters*            |                                                |             |
| SLC25A4                                | adCPEO, arCPEO, Myopathy, Cardiomyopathy       | AD, AR      |
| *Unclear functions*                    |                                                |             |
| FBXL4                                  | Encephalomyopathy,facialdysmorphism            | AR          |

- Abbreviations :: adCPEO, autosomal dominant chronic progressive
  external ophthalmoplegia; arCPEO, autosomal recessive chronic
  progressive external ophthalmoplegia; ANS, ataxia, neuropathy
  syndrome; IOSCA, infantile-onset spinocerebellar ataxia; MCHS,
  myocerebrohepatopathy syndrome; MNGIE, mitochondrial
  neurogastrointestinal encephalopathy; SMA, spinal motor atrophy.
